COVID-19 Drug Development Recent Advances, New Perspectives and Applications
COVID-19 is a rampant worldwide problem. It is caused by the SARS-CoV-2 virus and is manifest in different variants. The Delta variant compromised existing therapeutic and preventive options for this disease and is beginning to be replaced by the Omicron variant. Through pharmaceutical biotechnology...
Bewaard in:
Andere auteurs: | |
---|---|
Formaat: | Elektronisch Hoofdstuk |
Taal: | Engels |
Gepubliceerd in: |
IntechOpen
2022
|
Onderwerpen: | |
Online toegang: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Wees de eerste die reageert!